Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 4
2015 5
2016 7
2017 9
2018 6
2019 4
2020 1
2021 4
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Oncogenic PTEN functions and models in T-cell malignancies.
Tesio M, Trinquand A, Macintyre E, Asnafi V. Tesio M, et al. Among authors: trinquand a. Oncogene. 2016 Jul 28;35(30):3887-96. doi: 10.1038/onc.2015.462. Epub 2015 Nov 30. Oncogene. 2016. PMID: 26616857 Review.
Loss of ARHGEF1 causes a human primary antibody deficiency.
Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, Deau MC, Heurtier L, Meignin V, Picard C, Macintyre E, Alibeu O, Bras M, Molina TJ, Cavazzana M, André-Schmutz I, Durandy A, Fischer A, Oksenhendler E, Kracker S. Bouafia A, et al. Among authors: trinquand a. J Clin Invest. 2019 Mar 1;129(3):1047-1060. doi: 10.1172/JCI120572. Epub 2019 Feb 4. J Clin Invest. 2019. PMID: 30521495 Free PMC article.
Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies.
Pincez T, Bruneau J, Berteloot L, Piekarski E, Thomas C, Marçais A, Trinquand A, Castelle M, Garcelon N, Plantaz D, Cheminant M, Moshous D, Molina TJ, Hermine O, Macintyre E, Fischer A, Blanche S, Suarez F, Neven B. Pincez T, et al. Among authors: trinquand a. Haematologica. 2020 Sep 1;105(9):e461-464. doi: 10.3324/haematol.2019.230276. Haematologica. 2020. PMID: 33054064 Free PMC article. No abstract available.
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, Cording S, Trinquand A, Verkarre V, Lhermitte L, Brousse N, Jannot AS, Khater S, Frenzel L, Delarue R, Suarez F, Marçais A, Mulder CJ, Macintyre E, Asnafi V, Pouyet L, Bonnafous C, Lhospice F, Molina TJ, Meresse B, Cellier C, Cerf-Bensussan N, Hermine O; CELAC network°. Cheminant M, et al. Among authors: trinquand a. Gut. 2019 Aug;68(8):1396-1405. doi: 10.1136/gutjnl-2018-317371. Epub 2018 Nov 17. Gut. 2019. PMID: 30448772
An unusual case of acute leukemia.
Fleury C, Passet M, Settegrana C, Simon L, Chapiro E, Trinquand A, Safra Zaghouani I, Uzunov M, Le Garff-Tavernier M, Armand M, Costopoulos M. Fleury C, et al. Among authors: trinquand a. Ann Biol Clin (Paris). 2017 Jun 1;75(3):339-347. doi: 10.1684/abc.2017.1238. Ann Biol Clin (Paris). 2017. PMID: 28540857 Free article. English.
Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 Status.
Trinquand A, Plesa A, Abdo C, Subtil F, Aladjidi N, Rigaud C, Touzart A, Lhermitte L, Petit A, Michaux K, Jung C, Chassagne-Clement C, Asnafi V, Bertrand Y, Garnier N, Macintyre E. Trinquand A, et al. Hemasphere. 2021 Sep 6;5(10):e641. doi: 10.1097/HS9.0000000000000641. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34514345 Free PMC article.
Ongoing excellent outcomes with reduced toxicities following integration of molecular targeted therapies in pediatric anaplastic large cell lymphoma.
McCarthy P, Harford J, O'Marcaigh A, Malone A, Evans P, Sills A, Storey L, Rooney S, Betts D, O'Sullivan MJ, McDermott M, Bond J, Trinquand A, Smith OP. McCarthy P, et al. Among authors: trinquand a. Leuk Lymphoma. 2021 Aug;62(8):1995-1999. doi: 10.1080/10428194.2021.1894644. Epub 2021 Mar 8. Leuk Lymphoma. 2021. PMID: 33685326 No abstract available.
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.
Petit A, Trinquand A, Chevret S, Ballerini P, Cayuela JM, Grardel N, Touzart A, Brethon B, Lapillonne H, Schmitt C, Thouvenin S, Michel G, Preudhomme C, Soulier J, Landman-Parker J, Leverger G, Macintyre E, Baruchel A, Asnafi V; French Acute Lymphoblastic Leukemia Study Group (FRALLE). Petit A, et al. Among authors: trinquand a. Blood. 2018 Jan 18;131(3):289-300. doi: 10.1182/blood-2017-04-778829. Epub 2017 Oct 19. Blood. 2018. PMID: 29051182 Free article.
Immature acute leukaemias: lessons from the haematopoietic roadmap.
Lefeivre T, Jones L, Trinquand A, Pinton A, Macintyre E, Laurenti E, Bond J. Lefeivre T, et al. Among authors: trinquand a. FEBS J. 2022 Aug;289(15):4355-4370. doi: 10.1111/febs.16030. Epub 2021 Jun 10. FEBS J. 2022. PMID: 34028982 Review.
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.
Villarese P, Lours C, Trinquand A, Le Noir S, Belhocine M, Lhermitte L, Cieslak A, Tesio M, Petit A, LeLorch M, Spicuglia S, Ifrah N, Dombret H, Langerak AW, Boissel N, Macintyre E, Asnafi V. Villarese P, et al. Among authors: trinquand a. Leukemia. 2018 Jan;32(1):61-71. doi: 10.1038/leu.2017.176. Epub 2017 Jun 8. Leukemia. 2018. PMID: 28592888 Clinical Trial.
33 results